| Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours O Delattre, J Zucman, B Plougastel, C Desmaze, T Melot, M Peter, ... Nature 359 (6391), 162-165, 1992 | 2103 | 1992 |
| MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive … IM Ambros, PF Ambros, S Strehl, H Kovar, H Gadner, M Salzer‐Kuntschik Cancer 67 (7), 1886-1893, 1991 | 771 | 1991 |
| Ewing sarcoma: current management and future approaches through collaboration N Gaspar, DS Hawkins, U Dirksen, IJ Lewis, S Ferrari, MC Le Deley, ... Journal of Clinical Oncology 33 (27), 3036-3046, 2015 | 704 | 2015 |
| Ewing sarcoma TGP Grünewald, F Cidre-Aranaz, D Surdez, EM Tomazou, E de Álava, ... Nature reviews Disease primers 4 (1), 5, 2018 | 680 | 2018 |
| Ewing's sarcoma family of tumors: current management M Bernstein, H Kovar, M Paulussen, RL Randall, A Schuck, LA Teot, ... The oncologist 11 (5), 503-519, 2006 | 643 | 2006 |
| EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation GHS Richter, S Plehm, A Fasan, S Rössler, R Unland, IM Bennani-Baiti, ... Proceedings of the National Academy of Sciences 106 (13), 5324-5329, 2009 | 357 | 2009 |
| Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? A Zoubek, B Dockhorn-Dworniczak, O Delattre, H Christiansen, F Niggli, ... Journal of clinical oncology 14 (4), 1245-1251, 1996 | 345 | 1996 |
| Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the … MC Le Deley, O Delattre, KL Schaefer, SA Burchill, G Koehler, ... Journal of Clinical Oncology 28 (12), 1982-1988, 2010 | 255 | 2010 |
| Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. H Kovar, M Dworzak, S Strehl, E Schnell, IM Ambros, PF Ambros, ... Oncogene 5 (7), 1067-1070, 1990 | 233 | 1990 |
| DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ... Nature medicine 23 (3), 386-395, 2017 | 225 | 2017 |
| Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1 EM Tomazou, NC Sheffield, C Schmidl, M Schuster, A Schönegger, ... Cell reports 10 (7), 1082-1095, 2015 | 222 | 2015 |
| A molecular function map of Ewing's sarcoma M Kauer, J Ban, R Kofler, B Walker, S Davis, P Meltzer, H Kovar PloS one 4 (4), e5415, 2009 | 212 | 2009 |
| Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma S Postel-Vinay, AS Véron, F Tirode, G Pierron, S Reynaud, H Kovar, ... Nature genetics 44 (3), 323-327, 2012 | 206 | 2012 |
| EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro H Kovar, DNT Aryee, G Jug, C Henockl, M Schemper, O Delattre, ... Cell Growth and Differentiation-Publication American Association for Cancer …, 1996 | 206 | 1996 |
| EWS-FLI1 and EWS-ERG Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's Sarcoma JP Ginsberg, E de Alava, M Ladanyi, LH Wexler, H Kovar, M Paulussen, ... Journal of Clinical Oncology 17 (6), 1809-1809, 1999 | 200 | 1999 |
| Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II R Petermann, BM Mossier, DNT Aryee, V Khazak, EA Golemis, H Kovar Oncogene 17 (5), 603-610, 1998 | 183 | 1998 |
| Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells OM Tirado, S Mateo-Lozano, J Villar, LE Dettin, A Llort, S Gallego, J Ban, ... Cancer research 66 (20), 9937-9947, 2006 | 181 | 2006 |
| Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors H Kovar, G Jug, DNT Aryee, A Zoubek, P Ambros, B Gruber, R Windhager, ... Oncogene 15 (18), 2225-2232, 1997 | 172 | 1997 |
| Ewing sarcoma—diagnosis, treatment, clinical challenges and future perspectives SK Zöllner, JF Amatruda, S Bauer, S Collaud, E de Álava, SG DuBois, ... Journal of clinical medicine 10 (8), 1685, 2021 | 170 | 2021 |
| Dr. Jekyll and Mr. Hyde: the two faces of the FUS/EWS/TAF15 protein family H Kovar Sarcoma 2011 (1), 837474, 2011 | 149 | 2011 |
